Planning and producing basic sales promotion materials required for a new drug launch
Medical Writing
- Category
- Medical Writing
Approach
We produce the whole materials required at approval and product launch. We can take the initiative for the production, including the schedule management and the proposal of content to be published. We create drafts based on common technical documents (CTDs) and other references and engage in production under a system of thorough quality management, which includes checking the Code of Practice and error detection by our proofreaders.
Materials we produce
Summary of product information, summary of specific items on product information, Interviewer Forms, guide for appropriate use, demonstration slides, booklets on diseases, training texts for MR, e-learning, videos explaining the mechanism of action (3-D), videos explaining clinical studies, and materials for patients
Examples of past achievements
Mircera injection syringe (Chugai Pharmaceutical Co., Ltd.), Mucosta eye drop UD 2% (Otsuka Pharmaceutical Co., Ltd.), Requip CR tablet (GlaxoSmithKline K.K.), Savene IV drip (Kissei Pharmaceutical Co., Ltd.), Glash Vista topical solution 0.03% (Allergan Japan), Rapalimus tablets/Rapalimus Gel (Nobelpharma Co., Ltd.), Lenvima capsules (Eisai Co., Ltd.), Kanuma IV solution (Alexion Pharmaceuticals, Inc.), Regroth dental solution kit (Kaken Pharmaceutical Co., Ltd.), GALAFOLD Capsules (Amicus Therapeutics, Inc.)
